JPM8 is a novel sildenafil-like PDE5 inhibitor. Its efficacy was tested in vivo by the oral administration of drugs to a rat model and recording penile activity changes. Effect on the relaxation of the rabbit cavernosa was tested in vitro using an organ bath were drugs are added to the tissue media and relaxation was recorded using a transducer connected to a chart recorder. The accumulation of cGMP and cAMP was measured by incubation of cavernosa strips and then extracting the produced cGMP and cAMP in the incubation mixture, then quantitating it using ELISA. JPM8 showed increased and promoted sexual and penile activity in rats in a similar but slightly higher trend than the positive control sildenafil. JPM8 was more efficient in relaxing the rabbit corpora cavernosa than sildenafil. The cGMP and cAMP accumulation showed a similar trend for both drugs. We concluded that JPM8 was very effective in promoting sexual activity in rats, relaxing the corpora cavernosa and promoting cGMP accumulation in rabbits.
Introduction
Erectile dysfunction (ED) has been identified as 'the inability to attain and maintain penile erection sufficient for satisfactory sexual performance 0 . 1 Penile erection is a complex neurovascular event involving the interaction of three physiological systems: the central nervous system (CNS); the peripheral nervous system; and the penile arterial and trabecular smooth muscle. Relaxation of penile smooth muscle, which is necessary and crucial for erection, allows blood to flow into the penile structures resulting in the engorgement of the cavernosa tissue and increased cavernosal pressure. The penile smooth muscle relaxation is mainly mediated by nitric oxide (NO), which is released from non-adrenergic non-cholinergic neurons and from the endothelium upon sexual stimulation. Nitric oxide activates the cytoplasmic enzyme guanylate cyclase (GC) resulting in an enhanced formation of guanosine 3 0 ,5 0 -monophosphate (cGMP) that provides the signal leading to the smooth muscle relaxation. Elevated levels of cGMP in turn promote the efflux of Ca 2þ ions from the cavernosa smooth muscle cells. This efflux induces muscle relaxation, facilitates blood flow into the corpora cavernosa, and thereby helps to obtain and maintain penile erection. 2 Phosphodiesterase type 5 (PDE5), cGMP-binding cGMP-specific PDE, is distributed in lung, kidney, spleen, endothelial cells and smooth muscle cells, and plays a key role in the regulation of the cellular level of cGMP. In the corpora cavernosa, PDE5 degrades cGMP, leading to penile muscle contraction and detumescence. 2 Inhibition of PDE5 enhances the levels of cGMP leading to its accumulation resulting in facilitating and prolonging erection. 3 Many potent PDE5 inhibitors with a variety of scaffolds have been reported: zaprinast-related inhibitors, 4 quinazoline derivatives, 5 phthalazine derivatives, 6 tetracyclic diketopiperazines, 7 indoles, 8 pyrido[3,2,1-jk] carbazoles 9 and sildenafil analogues. 10 Animal models have accounted significantly for the amazing strides made in the field of sexual dysfunction research. Fundamentally, they have offered a unique experimental approach to test many aspects and hypotheses regarding sexual function. Among the scientific tools used in animal models for the investigation of penile erection are the varied techniques they afford for stimulation and monitoring of erectile responses in vivo. 11 Erection monitoring methods have included many techniques. 11 Erection monitoring by observation and counting phenomenal erections is a widely used technique due to its simplicity and direct in vivo comparison. 12, 13 Because of high purchase and maintenance costs of large animals as well as their diminishing availability for medical research, small mammalian species such as lagomorphs and rodents have become the primary models. The rabbit was found to be a valid model for the in vivo and in vitro assessment of erectile tissue function. 14 Once the rat was characterized to similarly provide a valid model for investigating penile erection, this species was then increasingly used. ,
In this paper we report the potency and activity of a novel molecule JPM8 15 in a rat animal model and its effect on the accumulation of cGMP and adenosine 3 0 ,5 0 -monophosphate (cAMP) in rabbit cavernosa together with its effect on the relaxation of isolated precontracted rabbit corpora cavernosa.
Comparison of JPM8 and sildenafil structures is shown in (Figure 1 ). 
Materials and methods

Materials
Effect on male rat erectile response
Based on preliminary studies to select the appropriate dose range for JPM8 and sildenafil, both drugs were administered separately to male Wistar rats weighing 200 -250 g by oral gavage in an appropriate vehicle (0.1% v=v HC1). For each dose the number of animals was 10 animals, and in one experiment doses used for both drugs were as follows: 0.0781, 0.1562, 0.3125 and 0.6250 mg=kg body weight. Experiments were repeated blindly three times using new fresh (unused) animals in each experiment. Results shown are the average of three experiments, thus each single dose represents 30 animals. Control animals were given the vehicles alone without the drug. Rats were placed in observation glass cages and were allowed free access to food and water. The animals were observed for 2 h after drug administration for penile erection, selfpenile suction and possible copulation mounting. Number of rats responding to this experiment protocol was recorded along with the number of sexual activity episodes (self-sucking, erection or copulation movements).
Relaxation of rabbit corpus cavernosa smooth muscle
Tissue preparation, mounting and equilibration. The penis of mature New Zealand rabbit (3.0 -4.0 kg) was dissected and freed of all surrounding tissue. The corpus cavernosa was cut lengthwise then cross-wise into strips. Each strip was about 2 mm thick and 7 -8 mm long. The strips were kept in well-oxygenated Krebs (Krebs solution contained (mmol=l), NaCl 125, NaHCO 3 20, KCl 4 , NaH 2 PO 4 1.8, MgSO 4 1.8, CaCl 2 1.8, glucose 10 and HEPES buffer 10, pH 7.2 -7.4). The solution was oxygenated with a gas mixture containing 95% O 2 and 5% CO 2 for 30 min and kept at 4 C until used. The tissue was mounted in a 25 ml tissue water-jacketed chamber and continuously oxygenated with a gas mixture containing 95% oxygen and 5% CO 2 for 1 h before A novel compound JPM8 TS El-Thaher et al starting the experiment. The muscle contracted against a weight of about 2 g. Harvard isotonic transducer recorded the contraction=relaxation of the muscle which was connected to Harvard Universal Oscillograph. Before each experiment the transducer was calibrated three times with 0.5 g weight.
Experimental protocol
The strips were equilibrated in Krebs for 1 h (at 37 C at all stages of experiment) before proceeding with the experiment. High K þ Krebs (K þ 109 mmol=l replaced NaC1) replaced the normal Krebs in the chambers and the isotonic contraction was recorded until reaching a steady state usually in about 15 -20 min. The strips were washed with normal Krebs at least twice and the muscles were allowed to return to complete relaxation (in about 30 min). The muscle was then contracted by replacing normal Krebs with that containing phenylephrine (250 mM). After reaching the peak of the force of contraction (approximately 5 -10 mm), the solution was replaced with Krebs containing phenylephrine (250 mM) and either sodium nitroprusside (SNP) alone (300 nM) or both SNP (300 nM) and one of the drugs, (sildenafil or JPM8, 100 -400 nM). The effect on relaxation was recorded over 30 min (n ¼ 10 for JPM8, n ¼ 8 for sildenafil). The recorded decrease in the force of contraction (residual contraction) was calculated as percentage (%) of the maximum contraction obtained with phenylephrine immediately before adding the drug. Measurements were made at 1, 2, 5, 10, 15, 20, 25 and 30 min. A representative record of experimental protocol is shown in Figure 2 .
Effect on the accumulation of cGMP and cAMP in rabbit corpus cavernosa smooth muscle New Zealand rabbits (3.0 -4.0 kg) males were used to get the penile strips as indicated above. Penile strips were placed in triplicates in 200 ml MEM containing various drug concentrations, and in the case of cGMP 10 mM SNP as a nitrogen donor was included in the MEM media. Each experiment was repeated three times. The strips were incubated at 37 C for 30 min. The reaction was stopped by adding 200 ml of 1.0 M perchloric acid. The incubation medium was sonicated for 5 min, then was neutralized with 240 ml of 0.5 M K 3 PO 4 Á3H 2 O. The mixture was centrifuged and the supernatant was collected and kept at 4
C. Aliquots at an appropriate dilution were assayed for the concentrations of cAMP and cGMP using ELISA following the manufacturers protocol as in the assay manual provided with the kits.
Results
Effect on male rat erectile response
As shown in Figure 3A , the erectile response was significantly increased upon the oral administration of JPM8, which showed a similar trend as the positive control sildenafil. The percentage of responding animals to this treatment was increased markedly from a minimum of 10% for control animals (given vehicle alone), to 83.3 and 73.3% for JPM8 and sildenafil, respectively. However, neither rat treated with either of these drugs showed any copulation-mounting behavior. This maximum increase was achieved at a similar dose of 0.625 mg=kg body weight for both drugs. It is clear from the increasing response and line regression analysis that a dose-dependent response was obtained for both drugs with JPM8 giving a slightly higher response (insert Figure 3A) . Linear regression statistical analysis showed a response curve with slopes of 109.2 (range 86 -133) and 81.3 (range 56 -106) for both JPM8 and sildenafil, respectively (full statistical data in Figure 3A legend). This increase and improvement of sexual response was even more obvious as shown in Figure 3B . The total number of erectile response episodes (including penile erection and self-sucking) was recorded for each different dose. Again the dose -response curve shows an improvement in erectile response upon the administration of these drugs in comparison to control. The maximum number of episodes was achieved at a dose of 0.625 mg=kg body weight. The total number of episodes obtained for JPM8 was 21 AE 1 episodes, while for sildenafil it was 12 AE 1.5 episodes. Penile erection index (PEI) at each dose Figure 2 Representative records of experimental protocol for the relaxation of isolated precontracted rabbit corpora cavernosa smooth muscle strips.
A novel compound JPM8 TS El-Thaher et al concentration was calculated by multiplying the percentage of active animals at each dose by the total number of activity episodes obtained at the same dose concentration as shown in Figure 3C . 16, 17 PEI improved with increasing dose. Maximum PEI values were obtained at the maximum dose of 0.625 mg=kg body weight for both drugs. For JPM8 calculated PEI was 1746 AE 61.1 and for sildenafil it was 923 AE 51.3. Effective dose ED 50 (the dose required to give 50% responding animals) for both drugs was calculated as 0.525 and 0.600 mmol=kg body weight for JPM8 and sildenafil, respectively, as shown in Figure 4 . ED 50 was calculated using a Probit analysis OW-Basic version 3.11 program with the percentage of responding animals as the input data.
Relaxation of contracted rabbit corpus cavernosa smooth muscle
Relaxation of the precontracted corpora cavernosa is expressed as the percentage residual contraction left at each dose (residual contraction (%) ¼ (maximum phenylephrine contraction as 100%) 7 (extent of relaxation (%) obtained at a particular drug concentration) JPM8 and sildenafil gradually relaxed the contracted corpus cavernosum strips over 30 min duration. The results suggest a two-stage effect, an initial fast phase over the first 10 min followed by slower phase over the next 20 min.
When comparing the effects of JPM8 with that of sildenafil ( Figure 5A ), we found JPM8 to be more Linear regression analysis for the JPM8 curve showed a line slope of 109.2 with an upper limit of 133 and lower limit of 86 with a P-value of 0.0004, r 2 0.98 at 95% confidence level. For sildenafil the curve slope was 81.3 with an upper limit of 106 and lower limit of 56 with a P-value of 0.002, r 2 0.97 at 95% confidence level. Anova analysis showed no significant differences between number of active animals when given equal does of either JPM8 or sildenafil. (B) Effect of oral administration of JPM8 and sildenafil on the enhancement of sexual activity in rats. The figure shows the total episodes of sexual activity in relation to increased dose. Each value represents the average of three experiments AE s.d. Anova analysis showed that number of episodes is significant only at 0.625 mg=kg (Pvalue 0.002, F-calculated=F-critical 67.6=7.7). (C) Effect of oral administration of JPM8 and sildenafil on the enhancement of sexual activity in rats. The figure shows penile erection index (PEI) in relation to increased dose. PEI was calculated as the percentage of active animals in one group multiplied by the total number of episodes in the same group at a certain dose. Each value represents the average of three experiments AE s.d. Anova analysis showed that the PEI is significant at lower doses with P-value 0.019, F-calculated=F-critical 14.7=7.7 at 0.078 mg=kg, P-value 0.009, F-calculated=F-critical 22.2=7.7 at 0.156 mg=kg, and P-value 0.0006, F-calculated=F-critical 319.4=7.7 at 0.625 mg=kg.
A novel compound JPM8
TS El-Thaher et al effective than sildenafil for the same dose. The results show JPM8 at 200 nM and in the presence of SNP (NO donor) produced relaxation in previously contracted corpora cavernosa strips with a residual contraction of 36 AE 6.1% (mean AE 1 s.e.m) after 30 min of incubation. Sildenafil, at 200 nM and in the presence of SNP, also produced relaxation in previously contracted strips but to a lesser extent than JPM8, with residual contraction of 56 AE 5.4% at 30 min. The relaxation produced by JPM8 was significant from the first min after adding the drug, but for sildenafil it became significant after 5 min. In the absence of SNP both drugs produced small relaxations which were not significantly different. Anova analysis showed that residual contraction was significant at all times between JPM8 and sildenafil (both with and without SNP) at 200 nM; calculated and critical F-values and P-values are summarized in the Figure 5A legend. Figure 5B shows that increasing concentrations of JPM8 100, 200 and 400 nM produced increasingly greater relaxation reaching maximum with residual contraction of 34 AE 5.7% at 400 nM and 30 min incubation. Anova analysis showed that a significant difference in the presence of SNP was obtained at all concentrations. From P-values obtained, significant difference was seen between 100 and 200 nm (P-value ¼ 0.023), while the difference between 200 and 400 nM was not significant. Figure 5A and B Figure 4 Comparison of effective dose for both JPM8 and sildenafil. Effective dose was the concentration required to initiate sexual activity in 50% of experimental animals under study. This was calculated from the number of active animals at each concentration. Each value represents the average of three experiments AE s.d. Figure 5 (A) Residual contraction as percentage of 100% contraction when corpus cavernosa smooth muscle (CCSM) strips were contracted with 250 mM phenylephrine. JPM8 and sildenafil were tested in the presence and absence of SNP. Phenylephrine and SNP baseline effect is also shown. Each value represents the average AE 1 s.e.m. where the number of experiments (n) was 10 for JPM8 and 8 for sildenafil. Anova analysis showed very significant differences at all times. F-and P-values were as shown in Table 1 . (B) Dose -response curves of JPM8 for the relaxation of precontracted rabbit CCSM strips. Response is expressed as residual contraction as percentage of the 100% contraction obtained with 250 mM phenylephrine. All doses were in the presence of SNP, and only JPM8 at 200 nM without SNP was included for comparison. Each value represents the average of three experiments AE 1 s.e.m. where the number of experiments (n) ranged between 8 and 10. Anova analysis showed very significant differences at all times for different JPM concentrations. F-and Pvalues were as shown in Table 2 . Effect on the accumulation of cGMP and cAMP in rabbit corpus cavernosa smooth muscle
In Figure 6A it can be seen that both JPM8 and sildenafil have very little effect on the levels of cGMP over the tested concentrations up to 100 000 nM in the absence of NO donor. When NO donor was added, an increasing response on cGMP accumulation was noticed which was directly proportional to concentration. JPM8 increased levels of cGMP giving maximum increase at about 10 000 nM. Sildenafil showed a similar effect giving a maximum increase at similar concentration levels. The final magnitude of increase in cGMP concentration was almost the same and equal for both JPM8 and sildenafil. Figure 6B shows a comparison between the effect of both compounds on the accumulation of cAMP levels in the absence of NO donor. Both JPM8 and sildenafil increased the levels of cAMP above intrinsic concentrations. JPM8 increased the levels of cAMP with a maximum increase between 8000 and 10 000 nM. Sildenafil showed a similar increase at a maximum concentration within a similar range.
Discussion and conclusion
The identification of the various PDE families has been paralleled by the synthesis of selective or partially selective inhibitors. Sildenafil is a selective inhibitor for PDE5, and it enhances NO-mediated relaxation of rabbit, rat, and human corpus cavernosa in vitro. 18 JPM8 is a novel compound of a series of compounds being designed as PDE5 inhibitors. Both JPM8 and sildenafil share structural similarities, as shown in Figure 1 . This similarity could attribute to a similar mode of action and activity profile and results do suggest such similarity. In this study we used the rat as an in vivo model in which we monitored the change in erectile response after the oral administration of drugs. The sexual cycle, including response and behavior leading to penile erection and self-sucking in rats, is distinct. 19 This process in normally proceeded by a self-grooming behavior, yawning, followed by penile erection which is physically clear, and then leading to the ultimate and final action of selfsucking which represents the end of the sexual cycle. 19, 20 This is the very first report giving direct in vivo effect of PDE5 inhibitors on the improvement of erectile response in rats as an evidence of suitability for erectile dysfunction treatment. As shown in Figure 3A , increasing oral dose of JPM8 gave a very significant increase in the percentage of animals experiencing increase in their penile activity. The obtained increase was maximum at a dose of 0.625 mg=kg body weight, increasing to 83 AE 5.7% from a basal value of 10% for the control animals. Sildenafil showed a similar increase trend with an increase of 73 AE 5.7% from the same basal value. Linear regression analysis showed an increasing response, which is obvious from the slopes obtained, as detailed in the Figure 3A legend. This enhancement of erectile response was further ascertained by the significant increase in the number of penile activity episodes as shown in Figure 3B . As Figure 6 (A) Effect of JPM8 and sildenafil on the accumulation of cGMP in the rabbit corpora cavernosa smooth muscle. Accumulation was determined in the absence and presence of SNP as a nitrogen donor. Each value represents the average of three experiments. (B) Effect of JPM8 and sildenafil on the accumulation of camp in the rabbit corpora cavernosa smooth muscle. Accumulation was determined in the absence and presence of SNP as a nitrogen donor. Each value represents the average of three experiments.
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TS El-Thaher et al shown in Figure 3C , it is quite obvious that JPM8 and sildenafil showed a very significant increase in the PEI. Anova analysis on the number of responding animals did not show any significant differences between JPM8 and sildenafil at all doses, and this was reflected in the very close ED 50 for both. When comparing the number of episodes obtained at each dose, analysis showed a significant difference only at the highest dose (P-value is 0.002 at 0.625 mg=kg). Analysis of the PET values proved and confirmed the ability and the usefulness of PET in the differentiation between the activity of both drugs. This was reflected in the fact that Anova analysis showed significant differences in PET at very low doses (P-values were 0.019 at 0.078mg=kg, 0.009 at 0.156 mg=kg and 0.006 at 0.625 mg=kg, and this is quite important for the comparison of activity. This model actually is quite simple and quick for initial screening purposes. It is also very reliable and it can be easily validated using different drugs not designed to have any sexual enhancement properties. This animal model was used successfully, with slight modification for the evaluation of the eurycoma longifolia Jack as an aphrodisiac. 17 Maeda et al, while working on a series of evaluations for a cognitive enhancer using rat models, discovered a cognitive enhancer that also possesses stimulating activity on penile erection. 20 The major PDE in rabbit corpora cavernosa is PDE5, in addition to small amounts of PDE1 and PDE2. PDE3, which contributes significantly to the total PDE activity in human cavernosa, is apparently lacking in the rabbit cavernosa. Consequently, the principle inhibition of PDE5 in the corpora cavernosa will lead to its relaxation. JPM8 caused a significant relaxation in rabbit cavernosum, as shown in Figure 5 . Comparing both JPM8 and sildenafil at equi-molar concentration of 200 nM in Figure 5A , both JPM8 and sildenafil produced significant relaxation in a similar trend but only in the presence of NO donor (SNP). The magnitude of relaxation produced by JPM8 was statistically significantly different from that of sildenafil, as shown by Anova analysis (Figure 5A legend) . The figure also shows the JPM8 relaxation effect became significant at=after the first minute. In comparison, the effect of sildenafil attained was significant at=after 5 min. Figure 5B suggests JPM8 to have a concentration-dependant effect (100, 200 and 400 nM) with maximum relaxation produced at 400 nM, and that was 66 AE 5.7% at the end of 30 min. The effect of 200 nM was less than that of 400 nM during the first 15 min, but became similar towards the end of the incubation period, which can be seen from Anova analysis P-values (Figure 5B legend). Chuang et al 21 showed significant relaxation in rabbit cavernosum was produced by 100 nM sildenafil after 4 min of incubation. Similarly in our study JPM8 at 100 nM produced significant relaxation after 5 minutes, but the relaxation was less in our study; however, this could be due to the different reference of contraction used for the calculation in both studies. In our study we used the maximum contraction produced by phenylephrine (250 mM) as a 100% contraction, which is normally greater than the maximum contraction produced with 109 mM K þ , which was used in the other study. Other studies also showed sildenafil to relax rabbit cavernosa with an EC 50 of 1.15 mM with maximum relaxation of 89%. 22 Our results emphasized the importance of nitric oxide donor (like SNP) in producing relaxation of the corpora smooth muscles for both drugs,which was previously demonstrated by Chuang et al. 21 Sildenafil alone did not cause relaxation) as shown in both this study and that of Chuang. Adding SNP with sildenafil or JPM8 in the incubation medium caused significant relaxation in both studies, which gave direct evidence that relaxation is NO-mediated. JPM8 at all concentrations tested needed SNP to cause significant relaxation. Both JPM8 and sildenafil showed a much stronger relaxation effect than other nonspecific PDE inhibitors, like IBMX (nonspecific), milirinone (PDE3-specific), rolipram (PDE4-specific), which indicates their specificity towards PDE5. 22 Sildenafil was shown also to relax electrically stimulated human cavernosal smooth muscle with a maximum relaxation at 1 mM, and this relaxation was shown to be concentration-dependent due to the promotion of NO-stimulated cGMP signal mediating relaxation. 18 These results suggest that sildenafil has no direct effect on cavernosal smooth muscle relaxation in the absence of sexual stimulation, which is preceded by release of NO from nerve terminals.
Sildenafil and other NO=GC=cGMP mediators did show corpora relaxation in other species. 23 -25 Investigating the sildenafil mechanism of action, sildenafil was found to increase intracellular concentration of cyclic GMP, 21, 26, 27 because of an amplification of the endogenous NO-cyclic GMP pathway. Intracellular cGMP levels were shown to be increased in human corpora cells upon exposure to sildenafil (up to 100 nM) or zaprinast (up to 30 mM) in the presence of SNP. 21, 28 In the present study we showed that JPM8 and sildenafil significantly increased the levels of cGMP and cAMP, but only in the presence of SNP, which is in agreement with previous studies. 21, 28 When SNP was added at 300 nM, JPM8 and sildenafil had a four-fold increase in cGMP levels, reaching a maximum at about 10 000 nM. Above this concentration JPM8 had no effect, but sildenafil had a further small increase as shown in Figure 6A . It can be suggested that both JPM8 and sildenafil increased the levels of cGMP in similar trends. Although sildenafil has been reported to be more specific to PDE5 (cGMP-specific), it caused an increase in intrinsic cAMP levels in rabbit cavernosa tissue, reaching maximum levels at 10 000 nM. Similar findings were obtained in Figure   A novel compound JPM8 TS El-Thaher et al 6B. Our results of sildenafil effect on cAMP and cGMP are in agreement with those of Kim et al 29 This might suggest some inhibitory effect of both JPM8 and sildenafil towards cGMP and cAMPdegrading enzymes. Kim et al 29 suggested that cAMP up-regulates intracellular cGMP levels in part by inhibition of PDE5 whereas cGMP down-regulates cAMP synthesis via a mechanism requiring Uprotein coupling of adenylate cyclase. Thus the increase in cAMP levels did point out that the cAMP pathway, which might be triggered by increasing cGMP, is of pivotal significance in mediating relaxation of penile erectile tissue in men and this should receive much attention and further investigation.
Using isolated rabbit cavernosa strips, Jeremy 26 reported that sildenafil did increase cGMP levels with a maximum effect of 5-fold in the absence of SNP, and 28-fold in the presence of SNP. While cyclic AMP levels were unaltered at all concentrations of SNP and sildenafil, unfortunately data was not shown. On the other hand, recently Steif et al.
showed that sildenafil did increase levels of cAMP (4-fold) in human cavernosa tissue, while cGMP levels were not significantly increased. 29 The above effects of JPM8 and sildenafil on cavernosal smooth muscle relaxation, therefore, could be due to increased cGMP levels, which would mediate such relaxation by lowering intracellular calcium. Since both drugs have very close structure, their mechanisms of action are presumably the same, ie inhibiting phosphodiesterase type 5 enzyme in the corpora cavernosa leading to accumulation of cGMP, thus reducing intracellular calcium. Since the presence of SNP is important for both JPM8 and sildenafil to produce relaxation, this supports the above notion that both have similar mechanism of action. Chuang et al 21 showed a significant correlation between the magnitude of relaxation and the levels of cGMP in strips of rabbit corpus cavernosum produced by sildenafil in the presence of SNP or by SNP alone. It might be suggested that JPM8 has a higher affinity for PDE5, which could explain the faster accumulation of cGMP. Recently, Moreland et al reported that vardenafil (a PDE5 inhibitor) produced cGMP accumulation in human corpora cavernosa tissue from 63% to 137% of basal levels, while equi-molar concentrations of sildenafil caused dose-dependent increase in intracellular levels from 27% to 60% of basal levels, without referring to the effect on cAMP levels. 28 Recently, it has been shown that sildenafil has a direct central role in increasing the medial preoptic area (MPOA) stimulated intracavernosal pressure response. 30 This led to the conclusion that alteration of the CNS NO=cGMP levels can affect erectile capacity in the rat model used. Since both JPM8 and sildenafil are structurally related, JPM8 might have a similar central effect and this requires further investigation.
We conclude that JPM8 has a similar effect as sildenafil in vivo and in vitro, It promoted erectile activity in rats in parallel to sildenafil but with a higher efficacy. The rat model used proved to be a very useful and convenient model for activity comparison. Also JPM8 showed a similar effect in vitro, since it relaxed rabbit corpora cavernosa which is believed to be as a consequence of increasing cGMP levels in the corpora tissue. However, the results suggest JPM8 to have more efficacy than sildenafil in producing cavernosal smooth muscle relaxation, hence enhancing penile erection. The effects of JPM8 still have to be validated in vivo by measuring intracavernosal pressure.
